Search

Your search keyword '"Chiusolo, P."' showing total 1,244 results

Search Constraints

Start Over You searched for: Author "Chiusolo, P." Remove constraint Author: "Chiusolo, P."
1,244 results on '"Chiusolo, P."'

Search Results

1. A new approach to principal-agent problems with volatility control

3. Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study

4. Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial

6. Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial

7. Safety of primary nasotracheal intubation in the pediatric intensive care unit (PICU)

8. Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT

9. ECP versus ruxolitinib in steroid-refractory chronic GVHD – a retrospective study by the EBMT transplant complications working party

10. Peer review of the pesticide risk assessment of the active substance Bacillus subtilis strain RTI477

11. Peer review of the pesticide risk assessment of the active substance Bacillus velezensis RTI301

12. Peer review of the pesticide risk assessment of the active substance amidosulfuron

13. Peer review of the pesticide risk assessment of the active substance flufenacet

14. Peer review of the pesticide risk assessment of the active substance bensulfuron‐methyl

15. The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center

16. BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA

17. Peer review of the pesticide risk assessment of the active substance Pythium oligandrum strain B301

18. Peer review of the pesticide risk assessment of the active substance 1‐methylcyclopropene

19. Peer review of the pesticide risk assessment of the active substance Phthorimaea operculella granulovirus

20. Peer review of the pesticide risk assessment of the active substance triclopyr (variant triclopyr‐butotyl)

21. Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study

22. Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT

23. Peer review of the pesticide risk assessment of the active substance paraffin oil (CAS 8042‐47‐5, chain lengths C17–C31)

24. Peer review of the pesticide risk assessment for the active substance difenoconazole in light of confirmatory data submitted

25. Peer review of the pesticide risk assessment of the active substance mepiquat (evaluated variant mepiquat chloride)

26. Peer review of the pesticide risk assessment of the active substance lenacil

27. Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review

28. Hematopoietic stem cell transplantation: an Italian monocentric experience on the health assessment and eligibility of adult-related donors

29. Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic

36. Peer review of the pesticide risk assessment of the active substance clove oil

37. Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction

38. Updated peer review of the pesticide risk assessment of the active substance dichlorprop‐P and variant dichlorprop‐P‐2‐ethylhexyl

39. Peer review of the pesticide risk assessment of the active substance quinolin‐8‐ol

40. CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES

41. FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells

42. Updated reasoned opinion on the toxicological properties and maximum residue levels (MRLs) for the benzimidazole substances carbendazim and thiophanate‐methyl

44. Correction: ESPNIC clinical practice guidelines: intravenous maintenance fluid therapy in acute and critically ill children— a systematic review and meta-analysis

45. Unplanned admissions after day-case surgery in an Italian third-level pediatric hospital: a retrospective study

46. Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia–like or acute lymphoblastic leukemia–like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study

47. Updated peer review of the pesticide risk assessment of the active substance pydiflumetofen

48. Acute graft versus host disease 1976–2020: reduced incidence and predictive factors

49. Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease

50. Targeted review of maximum residue levels (MRLs) for chlorfenapyr

Catalog

Books, media, physical & digital resources